However, in general, the gene dosage effects are observed in CMT1A disease caused by duplication of the PMP22 gene and in CMT2S caused by the mutations in the IGHMBP2 gene [26,27]. This evidence concerns the gene IGHMBP2 and Charcot-Marie-Tooth disease type 1A.